This inventor holds 3 USPTO granted patents. Top assignees: Targesome, Inc., Other. Active years: 1996-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 4 
1 out of 834,570 Years Active: 1996-2000
Title: Curtis Kang Song: Innovator in Targeted Polymerized Liposome Technology
Introduction
Curtis Kang Song is a notable inventor based in Sunnyvale, CA. He has made significant contributions to the field of biomedical technology, particularly in the development of targeted polymerized liposome diagnostic and treatment agents. With a total of 3 patents, his work has the potential to revolutionize how diseases are diagnosed and treated.
Latest Patents
One of Curtis's latest patents focuses on targeted polymerized liposome diagnostic and treatment agents. These polymerized liposome particles are linked to a targeting agent and may also be associated with a contrast enhancement agent. They can encapsulate treatment agents, such as proteins, drugs, or hormones, allowing for directed delivery to specific biological sites. This innovation enables in vitro and in vivo studies through various imaging techniques, including magnetic resonance and optical imaging, to observe the expression of molecules in cells and tissues during disease and pathology.
Another significant patent involves the use of polymerized lipid diagnostic agents. Similar to his previous work, these agents are designed to interact with biological targets, enhancing imaging capabilities and facilitating targeted treatment delivery. This dual functionality underscores the importance of Curtis's inventions in advancing medical diagnostics and therapeutics.
Career Highlights
Throughout his career, Curtis has worked with various companies, including Targesome, Inc. His experience in the industry has allowed him to refine his innovative ideas and bring them to fruition. His work has garnered attention for its potential applications in medical science.
Collaborations
Curtis has collaborated with notable individuals in his field, including Henry Y Li and Jeremy Kenji Kuniyoshi. These partnerships have contributed to the development and enhancement of his innovative technologies.
Conclusion
Curtis Kang Song is a pioneering inventor whose work in targeted polymerized liposome technology is paving the way for advancements in medical diagnostics and treatment. His contributions are significant and hold promise for future innovations in the healthcare sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile